» Articles » PMID: 11853818

Generation of Allocation Sequences in Randomised Trials: Chance, Not Choice

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2002 Feb 21
PMID 11853818
Citations 212
Authors
Affiliations
Soon will be listed here.
Abstract

The randomised controlled trial sets the gold standard of clinical research. However, randomisation persists as perhaps the least-understood aspect of a trial. Moreover, anything short of proper randomisation courts selection and confounding biases. Researchers should spurn all systematic, non-random methods of allocation. Trial participants should be assigned to comparison groups based on a random process. Simple (unrestricted) randomisation, analogous to repeated fair coin-tossing, is the most basic of sequence generation approaches. Furthermore, no other approach, irrespective of its complexity and sophistication, surpasses simple randomisation for prevention of bias. Investigators should, therefore, use this method more often than they do, and readers should expect and accept disparities in group sizes. Several other complicated restricted randomisation procedures limit the likelihood of undesirable sample size imbalances in the intervention groups. The most frequently used restricted sequence generation procedure is blocked randomisation. If this method is used, investigators should randomly vary the block sizes and use larger block sizes, particularly in an unblinded trial. Other restricted procedures, such as urn randomisation, combine beneficial attributes of simple and restricted randomisation by preserving most of the unpredictability while achieving some balance. The effectiveness of stratified randomisation depends on use of a restricted randomisation approach to balance the allocation sequences for each stratum. Generation of a proper randomisation sequence takes little time and effort but affords big rewards in scientific accuracy and credibility. Investigators should devote appropriate resources to the generation of properly randomised trials and reporting their methods clearly.

Citing Articles

Techniques for randomization and allocation for clinical trials.

Miola A, Esposito A, Miot H J Vasc Bras. 2025; 23():e20240046.

PMID: 39866165 PMC: 11758574. DOI: 10.1590/1677-5449.202400462.


Promoting safer gambling through social norms and goal setting: A qualitative process analysis of participants' experiences in the EROGamb 2.0 feasibility trial.

Bush-Evans R, Arden-Close E, Thomas S, McAlaney J, Wang R, Bolat E Internet Interv. 2025; 38:100790.

PMID: 39764431 PMC: 11702003. DOI: 10.1016/j.invent.2024.100790.


Evaluation of leukocyte-platelet rich fibrin as an antibiotic slow-release biological device in the treatment of moderate periodontitis: a randomized controlled clinical trial.

Omar Y, Rashidy M, Ahmed G, Aboulela A BMC Oral Health. 2024; 24(1):1530.

PMID: 39709402 PMC: 11662799. DOI: 10.1186/s12903-024-05254-x.


A scoping review of activities intended to reduce publication bias in randomised trials.

Hohlfeld A, Kredo T, Clarke M Syst Rev. 2024; 13(1):310.

PMID: 39707441 PMC: 11660680. DOI: 10.1186/s13643-024-02728-5.


The Effect of Bio-Electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients with Multiple Sclerosis: A Triple-Blind Randomized Clinical Trial.

Alzharani A, Alshami A, Abualait T, Azman H, Alshamrani F, Alzahrani Y J Clin Med. 2024; 13(23).

PMID: 39685520 PMC: 11642583. DOI: 10.3390/jcm13237060.